ProT2® MHC Class II Tetramers
ProT2® MHC Class II Tetramers
Kramer C. et al. (2020). “Generation and reactivity analysis of human recombinant monoclonal antibodies directed against epitopes on HLA-DR” AJT DOI: 10.1111/ajt.15950
Hartnell F. et al. (2020). Characterising HCV specific CD4+ T-cells following viral-vectored vaccination, directly acting anti-virals and spontaneous viral cure. https://doi.org/10.1002/hep.31160
Cianciotti B. et al. (2019). CD4+ memory stem T cells recognizing citrullinated epitopes are expanded in patients with rheumatoid arthritis and sensitive to tumor necrosis factor blockade. https://doi.org/10.1002/art.41157
Kramer C. et al. (2020). Generation and reactivity analysis of human recombinant monoclonal antibodies directed against epitopes on HLA-DR. https://doi.org/10.1111/ajt.15950
Gliwinski M. et al. (2020). Proinsulin-specific T regulatory cell may control immune responses in type 1 diabetes: implications for adoptive therapy. 10.1136/bmjdrc-2019-000873
Pro5® MHC Class I Pentamers
Pro5® MHC Class I Pentamers
Zhu, A., et al. (2025). Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID19 and establish polyfunctional resident memory in patient lungs. Nature. DOI: s41590-024-02072-9
Serafini B., et al. (2024). EBV infected cells in the multiple sclerosis brain express PD-L1: How the virus and its niche may escape immune surveillance. Neuroimmunology. DOI: j.jneuroim.2024.578314
Jung, et al. (2021). SARS-CoV-2 spike-specific nasal-resident CD49a+CD8+ memory T cells exert immediate effector functions with enhanced IFN-γ production. Nature. DOI: s41467-024-52689-5
Jung, et al. (2021). The generation of stem cell-like memory cells early after BNT162b2 vaccination is associated with durability of memory CD8+ T cell responses. Immunity. DOI: 10.1016/j.celrep.2022.111138
Jung, et al. (2021). SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells. Nature. DOI: s41467-021-24377-1
Rha, et al. (2020). PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19. Immunity. DOI: 10.1016/j.immuni.2020.12.002
Peng Y., Dong T., et al. (2020). Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients. Nature Immunology. DOI: 10.1038/s41590-020-0782-6
Ferdosi S. R. et. al. (2019). Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes. Nature Communications. DOI: 10.1038/s41467-019-09693-x
Serafini B. et al. (2019). Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism. J. Virology. DOI: 10.1128/JVI.00980-19
Chew G.M. et al. (2016). TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection. PLoS Pathog. DOI: 10.1371/journal.ppat.1005349
Magini D. et al. (2016). Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge. PLoS One. DOI: 10.1371/journal.pone.0161193
HLA Tissue Typing
ProMap® T Cell Proliferation Assay
ProImmune REVEAL & ProVE® Epitope Discovery
ProScern® DC-T Cell Assay
ProScern® DC-T Cell Assay
Jambari, N. et al (2021) Effect of O-linked glycosylation on the antigenicity, cellular uptake and trafficking in dendritic cells of recombinant Ber e 1. PLoS One 16: 10.1371/journal.pone.0249876 [PubMedID: 33914740]
Steven, J. et al (2017) In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties to Facilitate Clinical Development. Frontiers in Immunology. [PubMedID: 29109729]
ELISPOT Assay
ELISPOT Assay
ELISPOT Assay
ProPresent® Antigen Presentation Assay
ProPresent® Antigen Presentation Assay
ProPresent® Antigen Presentation Assay
ProMix™ Peptide Pools
ProMix™ Peptide Pools
ProMix™ Peptide Pools
thinkpeptides® Peptide Products
thinkpeptides® Peptide Products
ProImmune Peptides
CD1d Tetramers
Model Antigens
Vaccinia Virus
Vaccinia Virus
Vaccinia Virus
Trypanosoma Cruzi
Trypanosoma Cruzi
Trypanosoma Cruzi
Respiratory Syncytial Virus (RSV)
Respiratory Syncytial Virus (RSV)
Respiratory Syncytial Virus (RSV)
Mycobacterium Tuberculosis
Mycobacterium Tuberculosis
Mycobacterium Tuberculosis
Malaria
Listeria
Lymphocytic Choriomeningitis Virus (LCMV)
Lymphocytic Choriomeningitis Virus (LCMV)
Lymphocytic Choriomeningitis Virus (LCMV)
Influenza
Influenza
InfluenzaInfluenza
Human Papillomavirus (HPV)
Human Papillomavirus (HPV)
Human Papillomavirus (HPV)
Human T-lymphotropic Virus (HTLV)
Human T-lymphotropic Virus (HTLV)
Human T-lymphotropic Virus (HTLV)
Human Immunodeficiency Virus (HIV)
Human Immunodeficiency Virus (HIV)
Human Immunodeficiency Virus (HIV)Human Immunodeficiency Virus (HIV)
Human Herpes Virus (HHV/HSV)
Human Herpes Virus (HHV/HSV)
Human Herpes Virus (HHV/HSV) Description
Hepatitis C (HCV)
Hepatitis C (HCV)
Hepatitis C (HCV) Description
Hepatitis B (HBV)
Hepatitis B (HBV)
Hepatitis B (HBV) Description
Epstein-Barr Virus (EBV)
Epstein-Barr Virus (EBV)
Epstein-Barr Virus (EBV) Description
Cytomegalovirus (CMV)
Cytomegalovirus (CMV)
Cytomegalovirus (CMV) Description
Chlamydia
Chlamydia
Chlamydia Description
Cancer
Cancer
Cancer Description
Adenovirus
Adenovirus
Adenovirus Description
Autoimmunity
Autoimmunity
Autoimmunity Description
Allergy
Allergy
Allergy Description